Yichen Zheng
Overview
Explore the profile of Yichen Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
386
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oztoprak H, Gao S, Guiglielmoni N, Brandt A, Zheng Y, Errbii M, et al.
Sci Adv
. 2025 Jan;
11(4):eadn0817.
PMID: 39854451
Some unique asexual species persist over time and contradict the consensus that sex is a prerequisite for long-term evolutionary survival. How they escape the dead-end fate remains enigmatic. Here, we...
2.
Zheng Y, Shi F, Sun L, Guo J, Ren T, Ma J
Front Immunol
. 2025 Jan;
15:1512972.
PMID: 39744625
Background: Circadian rhythms in the immune system and anti-tumor responses are underexplored in cancer immunotherapy. Despite the success of immune checkpoint inhibitors (ICIs) in treating advanced biliary tract cancers (BTCs),...
3.
Cao K, Luo K, Zheng Y, Xue L, Huo W, Ruan P, et al.
J Mater Chem B
. 2024 Oct;
12(45):11648-11658.
PMID: 39415636
Microtubules are highly dynamic structures, and their dynamic instability is indispensable for not only cell growth and movement, but also stress responses, such as endoplasmic reticulum (ER) stress. Docetaxel, a...
4.
Otto M, Zheng Y, Grablowitz P, Wiehe T
Hum Genome Var
. 2024 Sep;
11(1):37.
PMID: 39313504
Genes with multiple copies are likely to be maintained by stabilizing selection, which puts a bound to unlimited expansion of copy number. We designed a model in which copy number...
5.
Guo J, Meng W, Li Q, Zheng Y, Yin H, Liu Y, et al.
Bioengineering (Basel)
. 2024 Jul;
11(7).
PMID: 39061745
The association between sarcopenia and the effectiveness of neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) remains uncertain. This study aims to examine the potential of sarcopenia as a predictive...
6.
Bai S, Yang Y, Sheng R, Qi Y, Jia Y, Wang X, et al.
J Colloid Interface Sci
. 2024 Apr;
665:855-862.
PMID: 38564949
Bacterial infections are the primary causes of infectious diseases in humans. In recent years, the abuse of antibiotics has led to the widespread enhancement of bacterial resistance. Concerns have been...
7.
Zheng Y, Sun L, Guo J, Ma J
Cancer Commun (Lond)
. 2023 Sep;
43(10):1071-1096.
PMID: 37718480
The advent of immunotherapy has significantly reshaped the landscape of cancer treatment, greatly enhancing therapeutic outcomes for multiple types of cancer. However, only a small subset of individuals respond to...
8.
Lin H, Zheng Y, Yang Y, Liu F, Yang K, Zhang B, et al.
Environ Res
. 2023 Jul;
235:116660.
PMID: 37451573
In order to gain a deeper understanding of the microbial interactions in wastewater treatment plants (WWTPs) in China and clarify the role of the core community in the microbial interactions...
9.
Chen Q, Wang X, Zheng Y, Ye T, Liu J, Wang J, et al.
Cancer
. 2023 Jul;
129(21):3405-3416.
PMID: 37395148
Background: Chronic inflammation is considered the most critical predisposing factor of hepatocellular carcinoma (HCC), with inflammatory cell heterogeneity, hepatic fibrosis accumulation, and abnormal vascular proliferation as prominent features of the...
10.
Guo J, Hu J, Zheng Y, Zhao S, Ma J
Br J Cancer
. 2023 Mar;
128(12):2141-2149.
PMID: 36871044
Triple-negative breast cancer (TNBC) accounts for 15-20% of all invasive breast cancer subtypes. Owing to its clinical characteristics, such as the lack of effective therapeutic targets, high invasiveness, and high...